693630151	693630151	CD	B-NP	O
|	|	NN	I-NP	O
SGHC	SGHC	NN	I-NP	O
|	|	NN	I-NP	O
56346849	56346849	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
5003552	5003552	CD	B-NP	O
|	|	CC	I-NP	O
10/30/2005	10/30/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
ALTERED	ALTERED	NNP	I-NP	I-protein
MENTAL	MENTAL	NNP	I-NP	I-protein
STATUS	STATUS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/25/2005	4/25/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/10/2005	2/10/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
KIZZIE	KIZZIE	NNP	B-NP	O
,	,	,	O	O
GONZALO	GONZALO	NNP	B-NP	O
ALPHONSO	ALPHONSO	NNP	I-NP	O
MD	MD	NNP	I-NP	O
SERVICE	SERVICE	NNP	I-NP	O
:	:	:	O	O
General	General	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

PRINCIPAL	PRINCIPAL	JJ	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Altered	Alter	VBN	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
and	and	CC	O	O
dyspnea	dyspnea	NN	B-NP	O
.	.	.	O	O

LIST	LIST	NN	B-NP	O
OF	OF	IN	B-PP	O
PROBLEMS	PROBLEMS	NN	B-NP	O
:	:	:	O	O
Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
stenting	stente	VBG	B-VP	O
,	,	,	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
and	and	CC	O	O
head	head	NN	B-NP	O
and	and	CC	O	O
neck	neck	NN	B-NP	O
squamous	squamous	JJ	I-NP	O
cell	cell	NN	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Barbieri	Barbieri	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
70-year-old	70-year-old	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
stenting	stente	VBG	B-VP	O
in	in	IN	B-PP	O
September	September	NNP	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
year	year	NN	I-NP	O
,	,	,	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
and	and	CC	O	O
head	head	NN	B-NP	O
and	and	CC	O	O
neck	neck	NN	B-NP	O
squamous	squamous	JJ	I-NP	O
cell	cell	NN	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
chemotherapy	chemotherapy	NN	B-NP	O
and	and	CC	I-NP	O
radiation	radiation	NN	I-NP	O
therapy	therapy	NN	I-NP	O
earlier	earlier	RBR	B-NP	O
this	this	DT	I-NP	O
year	year	NN	I-NP	O
,	,	,	O	O
presenting	present	VBG	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
and	and	CC	O	O
dyspnea	dyspnea	NN	B-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
his	his	PRP$	B-NP	O
stents	stent	NNS	I-NP	O
in	in	IN	B-PP	O
September	September	NNP	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
year	year	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
went	go	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
rehab	rehab	NN	I-NP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
home	home	NN	B-ADVP	O
where	where	WRB	B-ADVP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
mostly	mostly	RB	B-ADVP	O
in	in	IN	B-PP	O
bed	bed	NN	B-NP	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
methadone	methadone	NN	I-NP	O
dose	dose	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	B-protein
control	control	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
from	from	IN	B-PP	O
2.5	2.5	CD	B-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
to	to	TO	B-PP	O
4	4	CD	B-NP	O
.	.	.	O	O

in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
and	and	CC	O	O
5	5	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
noticed	notice	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
increased	increase	VBN	B-NP	O
lethargy	lethargy	NN	I-NP	O
.	.	.	O	O

So	So	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
self	self	PRP	B-NP	O
discontinued	discontinue	VBD	B-VP	O
his	his	PRP$	B-NP	O
methadone	methadone	NN	I-NP	O
for	for	IN	B-PP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
increased	increase	VBN	I-VP	O
cough	cough	NN	B-NP	O
and	and	CC	I-NP	O
tan	tan	NN	I-NP	O
sputum	sputum	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
just	just	RB	B-ADVP	O
completed	complete	VBD	B-VP	O
14-day	14-day	JJ	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	I-NP	O
cefpodoxime	cefpodoxime	NN	I-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
for	for	IN	B-PP	O
aspiration	aspiration	NN	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
G-tube	G-tube	NN	I-NP	O
for	for	IN	B-PP	O
failed	failed	JJ	B-NP	O
Speech	Speech	NNP	I-NP	O
and	and	CC	I-NP	O
Swallow	Swallow	NNP	I-NP	O
test	test	NN	I-NP	O
previously	previously	RB	B-ADVP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
received	receive	VBD	B-VP	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	I-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
other	other	JJ	I-NP	O
complaints	complaint	NNS	I-NP	O
on	on	IN	B-PP	O
review	review	NN	B-NP	O
of	of	IN	B-PP	O
system	system	NN	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	IN	B-PP	O
three	three	CD	B-NP	O
stents	stent	NNS	I-NP	O
in	in	IN	B-PP	O
January	January	NNP	B-NP	O
of	of	IN	B-PP	O
2005	2005	CD	B-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
NSTEMI	NSTEMI	NN	I-NP	B-DNA
,	,	,	O	O
right	right	JJ	B-NP	O
hip	hip	NN	I-NP	O
placement	placement	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
recent	recent	JJ	I-NP	O
aspiration	aspiration	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
,	,	,	O	O
discharged	discharge	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
Healtten	Healtten	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
on	on	IN	B-PP	O
4/30/05	4/30/05	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
type	type	NN	B-NP	O
2	2	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
carotid	carotid	NN	B-NP	O
endarterectomy	endarterectomy	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
with	with	IN	B-PP	O
most	most	JJS	B-NP	O
recent	recent	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
squamous	squamous	JJ	B-NP	O
cell	cell	NN	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
originally	originally	RB	B-VP	O
treated	treat	VBN	I-VP	O
in	in	IN	B-PP	O
1989	1989	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
head	head	NN	I-NP	O
and	and	CC	I-NP	O
neck	neck	NN	I-NP	O
and	and	CC	O	O
relapsed	relapse	VBD	B-VP	O
in	in	IN	B-PP	O
2005	2005	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
carbotaxol	carbotaxol	NN	I-NP	O
and	and	CC	O	O
radiation	radiation	NN	B-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Include	Include	VBP	B-VP	O
ECASA	ECASA	NN	B-NP	B-protein
325	325	CD	I-NP	I-protein
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
75	75	CD	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
metformin	metformin	NN	B-NP	O
850	850	CD	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
paroxetine	paroxetine	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
methadone	methadone	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Zofran	Zofran	NNP	B-NP	O
p.r.n.	p.r.n.	NNP	I-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
20	20	CD	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
lisinopril	lisinopril	VBP	B-VP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
once	once	RB	I-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
pyridoxine	pyridoxine	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
AND	AND	CC	I-NP	O
SOCIAL	SOCIAL	JJ	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
His	His	PRP$	B-NP	O
father	father	NN	I-NP	O
died	die	VBD	B-VP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
MI	MI	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
lives	live	VBZ	B-VP	O
in	in	IN	B-PP	O
Nah	Nah	NNP	B-NP	O
Tonco	Tonco	NNP	I-NP	O
Ette	Ette	NNP	I-NP	O
He	He	NNP	I-NP	O
smokes	smoke	VBZ	B-VP	O
half	half	PDT	B-NP	O
a	a	DT	I-NP	O
pack	pack	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
for	for	IN	B-PP	O
unknown	unknown	JJ	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
years	year	NNS	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAM	EXAM	NN	I-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
62	62	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
110/60	110/60	CD	I-NP	O
,	,	,	O	O
breathing	breathe	VBG	B-VP	O
at	at	IN	B-PP	O
20	20	CD	B-NP	O
breaths	breath	NNS	I-NP	O
per	per	IN	B-PP	O
minute	minute	NN	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
O2	O2	NN	I-NP	O
saturation	saturation	NN	I-NP	O
of	of	IN	B-PP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
appeared	appear	VBD	B-VP	O
tired	tire	VBN	I-VP	O
with	with	IN	B-PP	O
dry	dry	JJ	B-NP	O
mucous	mucous	JJ	I-NP	O
membranes	membrane	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
diffuse	diffuse	JJ	B-NP	O
rhonchi	rhonchi	NN	I-NP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
chest	chest	NN	I-NP	O
exam	exam	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
2/6	2/6	CD	I-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
heard	hear	VBN	B-VP	O
best	best	RB	B-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
apex	apex	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
abdomen	abdoman	NNS	I-NP	O
was	be	VBD	B-VP	O
soft	soft	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
nontender	nontender	JJ	I-ADJP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
G-tube	G-tube	JJ	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
clean	clean	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
extremities	extremity	NNS	I-NP	O
were	be	VBD	B-VP	O
warm	warm	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
x3	x3	NN	B-NP	O
on	on	IN	B-PP	O
initial	initial	JJ	B-NP	O
exam	exam	NN	I-NP	O
but	but	CC	O	O
this	this	DT	B-NP	O
waxed	wax	VBD	B-VP	O
and	and	CC	I-VP	O
waned	wan	VBD	I-VP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
inpatient	inpatient	JJ	I-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

PERTINENT	PERTINENT	NNP	B-NP	O
LABS	LABS	NNP	I-NP	O
:	:	:	O	O
Include	Include	VBP	B-VP	O
glucose	glucose	NN	B-NP	O
originally	originally	RB	B-ADVP	O
of	of	IN	B-PP	O
429	429	CD	B-NP	O
brought	bring	VBD	B-VP	O
down	down	RB	B-ADVP	O
with	with	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
to	to	TO	B-PP	O
85	85	CD	B-NP	O
,	,	,	O	O
cardiac	cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
a	a	DT	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
17.3	17.3	NN	B-NP	B-protein
and	and	CC	I-NP	O
hematocrit	hematocrit	NN	I-NP	O
of	of	IN	B-PP	O
31.2	31.2	CD	B-NP	O
,	,	,	O	O
but	but	CC	O	O
his	his	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
30s	30	NNS	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
right	right	RB	I-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
ill-defined	ill-defined	JJ	I-NP	O
opacity	opacity	NN	I-NP	O
concerned	concern	VBN	B-VP	O
for	for	IN	B-PP	O
atelectasis	atelectasis	NN	B-NP	O
versus	versus	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
head	head	NN	I-NP	O
CT	CT	NN	I-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
intracranial	intracranial	JJ	I-NP	O
abnormality	abnormality	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
borderline	borderline	JJ	I-NP	O
QT	QT	NN	I-NP	O
interval	interval	NN	I-NP	O
of	of	IN	B-PP	O
490	490	CD	B-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
ventricular	ventricular	JJ	B-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
and	and	CC	O	O
deep	deep	JJ	B-NP	O
T-wave	T-wave	NN	I-NP	O
inversions	inversion	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
lateral	lateral	JJ	I-NP	O
leads	lead	NNS	I-NP	O
but	but	CC	O	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
as	as	IN	B-PP	O
previous	previous	JJ	B-NP	O
EKGs	EKG	NNS	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
70-year-old	70-year-old	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
medical	medical	JJ	I-NP	O
problems	problem	NNS	I-NP	O
including	include	VBG	B-PP	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	I-NP	O
CHF	CHF	NN	I-NP	B-protein
and	and	CC	I-NP	O
cancer	cancer	NN	I-NP	O
with	with	IN	B-PP	O
head	head	NN	B-NP	O
and	and	CC	I-NP	O
neck	neck	NN	I-NP	O
presenting	present	VBG	B-VP	O
with	with	IN	B-PP	O
change	change	NN	B-NP	O
in	in	IN	B-PP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
possibly	possibly	RB	B-ADJP	O
due	due	JJ	I-ADJP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
methadone	methadone	NN	I-NP	O
dosage	dosage	NN	I-NP	O
versus	versus	IN	B-PP	O
infectious	infectious	JJ	B-NP	O
etiology	etiology	NN	I-NP	O
namely	namely	RB	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

Hyperglycemia	Hyperglycemia	NN	B-NP	O
at	at	IN	B-PP	O
admission	admission	NN	B-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
been	be	VBN	I-VP	O
contributory	contributory	JJ	B-ADJP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
Blood	Blood	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
growth	growth	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
cefotaxime	cefotaxime	NN	B-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
p.o.	p.o.	FW	B-NP	O
meds	med	NNS	I-NP	O
,	,	,	O	O
per	per	IN	B-PP	O
G-tube	G-tube	NNP	B-NP	O
meds	med	NNS	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
and	and	CC	I-NP	O
cefpodoxime	cefpodoxime	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
albuterol	albuterol	NN	I-NP	O
nebulizer	nebulizer	NN	I-NP	O
,	,	,	O	O
Atrovent	Atrovent	NNP	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
after	after	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
fluids	fluid	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
slight	slight	JJ	B-NP	O
improvement	improvement	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
,	,	,	O	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
respiratory	respiratory	JJ	I-NP	O
standpoint	standpoint	NN	I-NP	O
,	,	,	O	O
gradually	gradually	RB	B-VP	O
improved	improve	VBN	I-VP	O
with	with	IN	B-PP	O
marked	marked	JJ	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
activity	activity	NN	B-NP	O
and	and	CC	I-NP	O
alertness	alertness	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Neuro	Neuro	NN	B-NP	O
and	and	CC	I-NP	O
Psych	Psych	NN	I-NP	O
:	:	:	O	O
His	His	PRP$	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
due	due	JJ	B-ADJP	O
in	in	IN	B-PP	O
large	large	JJ	B-NP	O
part	part	NN	I-NP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
methadone	methadone	NN	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
dose	dose	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
off	off	RP	B-PRT	O
the	the	DT	B-NP	O
methadone	methadone	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
eventually	eventually	RB	I-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
Zyprexa	Zyprexa	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
and	and	CC	O	O
2.5	2.5	CD	B-NP	O
mg	mg	NN	I-NP	O
at	at	IN	B-PP	O
noon	noon	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
wax	wax	NN	B-NP	O
and	and	CC	I-NP	O
wane	wane	NN	I-NP	O
in	in	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
orientation	orientation	NN	I-NP	O
sometimes	sometimes	RB	B-ADVP	O
thinking	think	VBG	B-VP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
but	but	CC	O	O
he	he	PRP	B-NP	O
always	always	RB	B-ADVP	O
had	have	VBD	B-VP	O
the	the	DT	B-NP	O
correct	correct	JJ	I-NP	O
date	date	NN	I-NP	O
,	,	,	O	O
correct	correct	JJ	B-NP	O
season	season	NN	I-NP	O
and	and	CC	O	O
knew	know	VBD	B-VP	O
generally	generally	RB	B-ADVP	O
what	what	WP	B-NP	O
the	the	DT	B-NP	O
current	current	JJ	I-NP	O
events	event	NNS	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

Cardiovascularly	Cardiovascularly	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
gently	gently	RB	B-ADVP	O
but	but	CC	O	O
otherwise	otherwise	RB	B-VP	O
has	have	VBZ	I-VP	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
status	status	NN	B-NP	O
.	.	.	O	O

Palliative	Palliative	JJ	B-NP	O
care	care	NN	I-NP	O
:	:	:	O	O
Palliative	Palliative	NNP	B-NP	O
Care	Care	NNP	I-NP	O
made	make	VBD	B-VP	O
numerous	numerous	JJ	B-NP	O
recommendations	recommendation	NNS	I-NP	O
that	that	IN	B-NP	O
we	we	PRP	B-NP	O
followed	follow	VBD	B-VP	O
,	,	,	O	O
one	one	CD	B-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
treat	treat	VB	I-VP	O
with	with	IN	B-PP	O
Zyprexa	Zyprexa	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
noon	noon	NN	B-NP	O
to	to	TO	B-VP	O
stabilize	stabilize	VB	I-VP	O
his	his	PRP$	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
fluctuations	fluctuation	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
came	come	VBD	B-VP	O
with	with	IN	B-PP	O
uncertain	uncertain	JJ	B-NP	O
effect	effect	NN	I-NP	O
as	as	IN	B-PP	O
at	at	IN	B-PP	O
discharge	discharge	NN	B-NP	O
but	but	CC	O	O
overall	overall	JJ	B-ADVP	O
his	his	PRP$	B-NP	O
functionality	functionality	NN	I-NP	O
had	have	VBD	B-VP	O
improved	improve	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
time	time	NN	B-NP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
aware	aware	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
communicative	communicative	JJ	I-ADJP	O
was	be	VBD	B-VP	O
overall	overall	JJ	I-VP	O
lengthened	lengthen	VBN	I-VP	O
.	.	.	O	O

We	We	PRP	B-NP	O
also	also	RB	B-ADVP	O
started	start	VBD	B-VP	O
him	him	PRP	B-NP	O
on	on	IN	B-PP	O
fluconazole	fluconazole	NN	B-NP	O
IV	IV	CD	I-NP	O
and	and	CC	O	O
changed	change	VBD	B-VP	O
per	per	IN	B-PP	O
G-tube	G-tube	NN	B-NP	O
upon	upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
for	for	IN	B-PP	O
treatment	treatment	NN	B-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
thrush	thrush	NN	I-NP	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-ADJP	O
:	:	:	O	O
He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
Regular	Regular	JJ	B-NP	B-protein
Insulin	Insulin	NN	I-NP	I-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
tube	tube	NN	I-NP	O
feeds	feed	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
also	also	RB	B-ADVP	O
added	add	VBD	B-VP	O
insulin	insulin	NN	B-NP	O
NPH	NPH	NN	I-NP	O
standing	stand	VBG	B-VP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
at	at	IN	B-PP	O
morning	morning	NN	B-NP	O
.	.	.	O	O

Code	Code	NN	B-NP	O
status	status	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
possibility	possibility	NN	I-NP	O
of	of	IN	B-PP	O
DNR/DNI	DNR/DNI	NN	B-NP	O
was	be	VBD	B-VP	O
discussed	discuss	VBN	I-VP	O
at	at	IN	B-PP	O
length	length	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
family	family	NN	I-NP	O
and	and	CC	O	O
they	they	PRP	B-NP	O
repeatedly	repeatedly	RB	B-VP	O
and	and	CC	I-VP	O
ultimately	ultimately	RB	I-VP	O
decided	decide	VBD	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
Mr.	Mr.	NNP	B-NP	O
Lieber	Lieber	NNP	I-NP	O
be	be	VB	B-VP	O
DNR/DNI	DNR/DNI	NNP	B-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
point	point	NN	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
understand	understand	VBP	B-VP	O
the	the	DT	B-NP	O
ramifications	ramification	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
and	and	CC	O	O
are	be	VBP	B-VP	O
comfortable	comfortable	JJ	B-ADJP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
decision	decision	NN	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Mcgown	Mcgown	NNP	I-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-VP	O
rehab	rehab	VB	I-VP	O
at	at	IN	B-PP	O
Emplupe	Emplupe	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Taglialatela	Taglialatela	NNP	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
oncologist	oncologist	NN	I-NP	O
.	.	.	O	O

FOLLOWING	FOLLOWING	VBG	B-VP	O
PHYSICIAN	PHYSICIAN	NN	B-NP	O
:	:	:	O	O
Fletcher	Fletcher	NNP	B-NP	O
Valladares	Valladares	NNP	I-NP	O
,	,	,	O	O
MD	MD	NNP	B-NP	O
eScription	eScription	NN	I-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
9-5877284	9-5877284	CD	B-NP	O
CS	CS	NN	I-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
Er-west	Er-west	NNP	B-NP	O
Vewina	Vewina	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Darrick	Darrick	NNP	B-NP	O
Stodghill	Stodghill	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Oncology	Oncology	NNP	I-NP	O
,	,	,	O	O
Tonbrooks	Tonbrooks	NNP	B-NP	O
Rence	Rence	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
A	A	NNP	I-NP	O
Ham	Ham	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
MUSKETT	MUSKETT	NNP	B-NP	O
,	,	,	O	O
DARREL	DARREL	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
REDING	REDING	NNP	B-NP	O
,	,	,	O	O
TOM	TOM	NNP	B-NP	O
ABDUL	ABDUL	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
3492344	3492344	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
5/7/05	5/7/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
5/7/05	5/7/05	CD	B-NP	O

